ストックスクリーナーアプリを入手
2.31
2.53%
-0.06
前日終値:
$2.37
開ける：
$2.38
24時間の取引高:
40,393
Relative Volume:
1.20
時価総額：
$70.43M
収益：
$300.00K
当期純損益:
$-40.16M
株価収益率:
-1.7535
EPS:
-1.3174
ネットキャッシュフロー:
$-42.36M
1週間 パフォーマンス:
-0.86%
1か月 パフォーマンス:
-3.75%
6か月 パフォーマンス:
-8.70%
1年 パフォーマンス:
-11.15%
1日の値動き範囲:
$2.31
$2.39
1週間の範囲:
$2.31
$2.40
52週間の値動き範囲:
$2.09
$3.61
Xbiotech Inc Stock (XBIT) Company Profile
Compare XBIT vs VRTX, REGN, ARGX, ALNY, RVMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
XBIT
Xbiotech Inc
|
2.31 | 70.43M | 300.00K | -40.16M | -42.36M | -1.3174 |
VRTX
Vertex Pharmaceuticals Inc
|
451.63 | 114.63B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
609.94 | 63.95B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
877.72 | 54.58B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
278.09 | 37.13B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
162.99 | 34.65B | 742.00K | -1.37B | -1.07B | -7.0731 |
Xbiotech Inc Stock (XBIT) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2019-06-14 | 開始されました | Piper Jaffray | Overweight |
| 2017-04-21 | ダウングレード | Noble Financial | Buy → Hold |
| 2016-06-28 | 繰り返されました | Noble Financial | Buy |
Xbiotech Inc (XBIT) 最新ニュース
XBiotech Inc (XBIT) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
XBiotech Inc (XBIT) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
XBiotech Inc (XBIT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
XBiotech Inc (XBIT) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
XBiotech Inc (XBIT) Valuation: PE, PB & Fair Value Analysis - TradingKey
XBiotech Inc (XBIT) Institutional Confidence - TradingKey
XBiotech Inc (XBIT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
XBiotech Inc (XBIT) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
XBiotech Inc (XBIT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
XBiotech Receives Authorization for V-SPINE Trial - Intellectia AI
XBiotech Inc Stock (US9840001002): FDA clears Phase II V-SPINE trial for vilamakitug in axial spondy - AD HOC NEWS
XBiotech (XBIT) Receives FDA Nod for V-SPINE Study - GuruFocus
XBiotech clears FDA review for axial spondyloarthritis study - Investing.com
FDA review lets XBiotech resume rheumatology with axial spondyloarthritis trial - Stock Titan
XBiotech Inc. (XBIT) Holds Near Support Amidst Minor DeclinesDescending Triangle - newsline.com
XBIT Should I Buy - Intellectia AI
XBiotech Inc stock (US9840001002): shares little changed as investors await next earnings update - AD HOC NEWS
XBiotech Inc. (XBIT) Slips 2.27% as Stock Tests Key Support LevelsMotive Wave - The Legal Advocate
XBiotech Inc. (XBIT) Edges Higher, Approaching Key Resistance at $2.56Trading Ideas - The Legal Advocate
XBiotech Inc. (XBIT) Edges Higher on Modest Volume, Tests Resistance Near $2.58Composite Profile - The Legal Advocate
XBIT | XBiotech Inc Insider Trading - Quiver Quantitative
XBiotech stock (US9840001002): Clinical-stage biotech stays in focus - AD HOC NEWS
XBiotech: Q1 Earnings Snapshot - Stamford Advocate
XBiotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
XBiotech (NASDAQ: XBIT) trims Q1 2026 loss, holds $115.5M cash and cuts R&D spend - Stock Titan
XBiotech’s New Axial Spondyloarthritis Trial Puts Vilamakitug on Investors’ Radar - TipRanks
TradingKey - TradingKey
Number of shareholders of XBiotech, Inc. – FWB:4XB - TradingView
XBiotech (XBIT) Projected to Post Earnings on Tuesday - MarketBeat
XBIT (XBiotech) reports zero Q1 2020 EPS missing estimates, shares dip 0.78 percent amid investor concern.Post Announcement - newser.com
XBiotech Inc. 2025 Executive Compensation, Board Structure, and Shareholder Ownership Overview - Minichart
Executive pay and governance detailed in XBiotech (NASDAQ: XBIT) 10-K/A - Stock Titan
XBIT Stock: A Comprehensive Guide to XBiotech Inc. - Bitget
XBIT (XBiotech) posts 100 percent Q1 2020 EPS miss, falls 0.79 percent on soft investor sentiment.Trader Community Insights - newser.com
XBIT (XBiotech Inc.) reports 100 percent Q1 2020 EPS miss, while shares notch mild gains on upbeat investor sentiment.Dividend Cut Risk - Xã Thanh Hà
XBiotech (XBIT) Stock: Price Action Overview (Smart Money Active) 2026-04-18Verified Analyst Reports - Xã Vĩnh Công
Short Interest in XBiotech Inc. (NASDAQ:XBIT) Grows By 21.3% - MarketBeat
Aug PostEarnings: Is XBiotech Inc part of any major index2026 Big Picture & Daily Volume Surge Signals - baoquankhu1.vn
Why is XBiotech (XBIT) Stock underperforming the market | Price at $2.33, Down 0.21%Synthetic Long - newsline.com
Insider Buy: Is XBiotech Inc stock risky to hold nowMarket Performance Summary & Capital Efficiency Focused Strategies - baoquankhu1.vn
XBiotech (NASDAQ:XBIT) Stock Passes Below Fifty Day Moving AverageShould You Sell? - MarketBeat
CEO Moves: Is XBiotech Inc likely to announce a buybackShare Buyback & Risk Managed Investment Signals - baoquankhu1.vn
Is XBiotech (XBIT) Stock Worth Holding | Price at $2.38, Up 1.28%Volatility Term Structure - newsline.com
Winners Losers: Can XBiotech Inc lead its sector in growth2026 Earnings Surprises & Growth Focused Entry Point Reports - baoquankhu1.vn
XBIT Stock Analysis: XBiotech Inc. at $2.34, mild 0.43% dip amid biotech sector activity - Newser
Wolverine World Wide Stock: Navigating Challenges in the Competitive Footwear Sector for Long-Term V - AD HOC NEWS
Published on: 2026-03-31 08:55:40 - baoquankhu1.vn
Are short sellers targeting XBiotech (XBIT) Stock | Price at $2.28, Down 2.15%Index Put Call - newsline.com
Stock List: Research Stocks from Around the World - GuruFocus
XBiotech Inc stock faces biotech sector headwinds amid pipeline uncertainty and market volatility - AD HOC NEWS
Comparing XBiotech (NASDAQ:XBIT) & IN8bio (NASDAQ:INAB) - Defense World
Xbiotech Inc (XBIT) 財務データ
収益
当期純利益
現金流量
EPS
0.74%
1.44%
大文字化:
|
ボリューム (24 時間):